Neupro
Links shared publicly online about this topic
Neupro improves quality of life in Parkinson's disease patients
news-medical.net — “People with Parkinson's disease who used once-daily Neupro® (rotigotine) in the RECOVER trial achieved improvements in quality of life, in addition to previously reported beneficial effects on motor and non-motor symptoms.” View full resource at news-medical.net
Most Recently Shared on October 4, 2010 at 10:38 am By:
Neupro improves quality of life in Parkinson's disease patients: People with Parkinson's disease who used once-dai... http://bit.ly/d5xo0c
UCB Receives Complete Response Letter From U.S. FDA Regarding Neupro(E) (Rotigotine)
medicalnewstoday.com — “UCB announced today that the U.S. Food and Drug Administration (FDA) has provided a complete response letter recommending reformulation of Neupro® (Rotigotine Transdermal System) before making” View full resource at medicalnewstoday.com
Most Recently Shared on April 26, 2010 at 4:12 pm By:
MNT Parkinson's News Health News
UCB Receives Complete Response Letter From U.S. FDA Regarding Neupro(E) (Rotigotine) http://mnt.to/3BL7 #parkinsons
Neupro improves wellbeing impaired by pain related to Restless Legs Syndrome
news-medical.net — “The first data to show that Neupro® (rotigotine transdermal system) significantly improved wellbeing and daily activities that are often impaired by pain related to Restless Legs Syndrome (RLS) were presented this week at the 14th International Congress of Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.” View full resource at news-medical.net
Most Recently Shared on June 18, 2010 at 2:05 pm By:
Neupro improves wellbeing impaired by pain related to Restless Legs Syndrome: The first data to show that Neupro® ... http://bit.ly/9aLXW7
Neupro® (Rotigotine) Provided Clinically Relevant Improvements In Health-Related Quality Of Life For People With Parkinson's Disease
medicalnewstoday.com — “People with Parkinson's disease who used once-daily Neupro® (rotigotine) in the RECOVER trial achieved improvements in quality of life, in addition to previously reported beneficial effects on” View full resource at medicalnewstoday.com
Most Recently Shared on October 1, 2010 at 3:05 pm By:
MNT Clinical Trials Health News
Neupro® (Rotigotine) Provided Clinically Relevant Improvements In Health-Related Quality Of Life For People With P... http://mnt.to/3KCB
Study Showed The Clinically Significant Therapeutic Benefit Of Neupro® (Rotigotine Transdermal System) In The Treatment Of Restless Legs Syndrome
medicalnewstoday.com — “UCB announced the results of a 6-month, randomized, double-blind, placebo-controlled clinical study, published in the journal Movement Disorders, showing that Neupro® (rotigotine transdermal s” View full resource at medicalnewstoday.com
Most Recently Shared on July 29, 2010 at 2:06 pm By:
MNT Neurology News Neurology and Health News
Study Showed The Clinically Significant Therapeutic Benefit Of Neupro® (Rotigotine Transdermal System) In The Trea... http://mnt.to/3GJp
Neupro® (Rotigotine Transdermal System) Significantly Improved Wellbeing And Daily Activities Impaired Due To Limb Pain
medicalnewstoday.com — “The first data to show that Neupro® (rotigotine transdermal system) significantly improved wellbeing and daily activities that are often impaired by pain related to Restless Legs Syndrome (RLS” View full resource at medicalnewstoday.com
Most Recently Shared on June 19, 2010 at 1:04 pm By:
MNT Pharma News Health News and Pharma
Neupro® (Rotigotine Transdermal System) Significantly Improved Wellbeing And Daily Activities Impaired Due To Limb... http://mnt.to/3F6r
New Data Show Low Incidence Of Augmentation Of Restless Legs Syndrome With 5-Year Neupro(R) (Rotigotine) Treatment
medicalnewstoday.com — “New 5-year data from the longest prospective open-label Restless Legs Syndrome (RLS) study to date, show that Neupro® (rotigotine) demonstrated continued symptomatic clinical benefit with a lo” View full resource at medicalnewstoday.com
Most Recently Shared on April 14, 2011 at 8:05 am By:
New Data Show Low Incidence Of Augmentation Of Restless Legs Syndrome With 5-Year Neupro(R) (Rotigotine) Treatment http://mnt.to/3TCC
Neupro (R) (Rotigotine Transdermal System) Improved Both Motor And Non-Motor Symptoms Of Parkinson's Disease
medicalnewstoday.com — “Evidence of Neupro® (Rotigotine Transdermal System) improving motor as well as non-motor symptoms of Parkinson's disease was presented at the 62nd American Academy of Neurology annual meeting” View full resource at medicalnewstoday.com
Most Recently Shared on April 15, 2010 at 6:11 pm By:
MNT Parkinson's News Health News
Neupro (R) (Rotigotine Transdermal System) Improved Both Motor And Non-Motor Symptoms Of Parkinson's Disease http://mnt.to/3BhH #parkinsons
The 62nd American Academy Of Neurology Meeting In Toronto, Canada: Extensive Neupro (R) (Rotigotine Transdermal System) Data To Be Presented
medicalnewstoday.com — “Extensive new data on rotigotine will be presented at the 62nd American Academy of Neurology annual meeting in Toronto, Canada between April 10th and 17th, 2010.At a series of oral and p” View full resource at medicalnewstoday.com
Most Recently Shared on April 9, 2010 at 4:08 pm By:
MNT Neurology News Neurology and Health News
The 62nd American Academy Of Neurology Meeting In Toronto, Canada: Extensive Neupro (R) (Rotigotine Transdermal System... http://mnt.to/3B3r
New Data Show Sustained 5-Year Benefit Of Neupro(R) (Rotigotine Transdermal System) For Symptoms Of Restless Legs Syndrome
medicalnewstoday.com — “New data presented at the 62nd American Academy of Neurology annual meeting in Toronto, Canada, showed that patients with moderate to severe Restless Legs Syndrome (RLS) using rotigotine achieved” View full resource at medicalnewstoday.com
Most Recently Shared on April 14, 2010 at 3:30 pm By:
New Data Show Sustained 5-Year Benefit Of Neupro(R) (Rotigotine Transdermal System) For Symptoms Of Restless Legs Synd... http://mnt.to/3BcC
Investegate |UCB Announcements | UCB: UCB brings Neupro® back to all patients in Europe
investegate.co.uk — “Investegate announcements from UCB, UCB brings Neupro® back to all patients in Europe” View full resource at investegate.co.uk
Most Recently Shared on June 29, 2009 at 4:03 pm By:
Parkinson's UK Health Organization and Research
Pharmaceutical group UCB says European Commission has lifted restrictions on its Parkinson's disease drug Neupro http://tinyurl.com/r5avhs
Neupro® approved by U.S. FDA for Parkinson's disease and Restless Legs Syndrome
worldpharmanews.com — “World Pharma News - one of the world's leading web-based pharmaceutical news publications - is committed to providing and disseminating the most prominent pharmaceutical news and achievements.” View full resource at worldpharmanews.com
Most Recently Shared on April 4, 2012 at 1:00 am By:
Jerome P. Lisk, M.D. Doctor, Neurologist, and Physician
Neupro® approved by U.S. FDA for Parkinson's disease and Restless Legs Syndrome: http://t.co/XFmE6ppG via @AddThis
Neupro (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinson's Disease - Drugs.com MedNews
drugs.com — “- Quality of life data from the RECOVER study presented at World Parkinson Congress People with Parkinson s disease who used once-daily Neupro (rotigotine) in t” View full resource at drugs.com
Most Recently Shared on September 30, 2010 at 9:15 pm By:
Drugs and Devices OW OW Health
Neupro (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People wi... http://bit.ly/bjwric #drug
Post Hoc Analysis From RECOVER Study Examined Effects Of Neupro(R) (Rotigotine) On Surrogate Markers Of Mood And Anhedonia In Parkinson's Disease
medicalnewstoday.com — “A post hoc analysis from the RECOVER study (Randomized Evaluation of the 24-hour Coverage: Efficacy of Rotigotine) suggested that patients with Parkinson's disease who used Neupro® (rotigotine” View full resource at medicalnewstoday.com
Most Recently Shared on June 9, 2011 at 10:05 am By:
MNT Parkinson's News Health News
Post Hoc Analysis From RECOVER Study Examined Effects Of Neupro(R) (Rotigotine) On Surrogate Markers Of Mood And Anhed... http://mnt.to/3WYC
New Post Hoc Analyses Examined The Effects Of Neupro(R) (Rotigotine) On Daytime Functioning, Daytime Symptoms, Pain And Mood In Restless Legs Syndrome
medicalnewstoday.com — “Results from new post hoc analyses assessing the effects of Neupro® (rotigotine) in Restless Legs Syndrome (RLS) and utilizing novel surrogate markers suggested improved daytime functioning an” View full resource at medicalnewstoday.com
Most Recently Shared on June 10, 2011 at 9:07 am By:
New Post Hoc Analyses Examined The Effects Of Neupro(R) (Rotigotine) On Daytime Functioning, Daytime Symptoms, Pain An... http://mnt.to/3X36
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
News-Medical.Net
Medical News from Around the World
-
MNT Parkinson's News
The latest parkinson's disease news published daily. Articles from research centers, universities and prestigious journals.
-
News-Medical.Net
Medical News from Around the World
Advertisement
